Clinical validation of engineered CRISPR/Cas12a for rapid SARS-CoV-2 detection.
Long T NguyenSantosh R RananawareBrianna Lauren Maria PizzanoBrandon T StonePiyush K JainPublished in: Communications medicine (2022)
CRISPR-based diagnostic platforms offer many advantages as compared to conventional qPCR-based detection methods. Our work here provides clinical validation of ENHANCE and its improved form ENHANCEv2 for the detection of COVID-19.